Amyris completes $84.8 million IPO, no effect on other, less qualified, IPO hopefuls

October 12, 2010 | Analyst Insight

Last week, Amyris Biotechnologies raised $84.8 million in its initial public offering (IPO), below its target of $100 million. At week's end, the stock was trading at about $17 a...